Treatment with CB2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice
Hypercholesterolemia is one of the most important risk factors for erectile dysfunction, mostly due to the impairment of oxidative stress and endothelial function in the penis. The cannabinoid system might regulate peripheral mechanisms of sexual function; however, its role is still poorly understoo...
Saved in:
| Main Authors: | Rodrigo Araujo Fraga-Silva, Fabiana Pereira Costa-Fraga, Fabrizio Montecucco, Younouss Faye, Silvia Quintao Savergnini, Sébastien Lenglet, François Mach, Sabine Steffens, Nikolaos Stergiopulos, Robson Augusto Souza dos Santos, Rafaela Fernandes da Silva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2013/263846 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurobiological Sequelae of the Passive or Voluntary Administration of the Synthetic Cannabinoid Receptor Agonist JWH-018
by: M.A. De Luca
Published: (2024-12-01) -
Structural mechanism of CB1R binding to peripheral and biased inverse agonists
by: Punita Kumari, et al.
Published: (2024-12-01) -
Evaluation of antioxidant and anti-hypercholesterolemic potential of Vitis vinifera leaves
by: Sushma Devi, et al.
Published: (2017-09-01) -
CO13 | Genetic background in hypercholesterolemic patients framing cardiovascular risk
Published: (2025-08-01) -
Diet-Induced Abdominal Obesity, Metabolic Changes, and Atherosclerosis in Hypercholesterolemic Minipigs
by: Ahmed Ludvigsen Al-Mashhadi, et al.
Published: (2018-01-01)